JOHN E MADEWELL to Neoadjuvant Therapy
This is a "connection" page, showing publications JOHN E MADEWELL has written about Neoadjuvant Therapy.
Connection Strength
0.076
-
Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard. Sci Rep. 2017 09 19; 7(1):11836.
Score: 0.056
-
Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI. Br J Cancer. 2015 Nov 03; 113(9):1282-8.
Score: 0.012
-
18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma. J Nucl Med. 2009 Mar; 50(3):340-7.
Score: 0.008